Visualitzant Sistema Sanitari Integral d'Utilització Pública de Catalunya - SISCAT per títol
Ara mostrant els elements 461-480 d 4260
-
BCL3 rearrangements in B-cell lymphoid neoplasms occur in two breakpoint clusters associated with diferent diseases
(Ferrata Storti Foundation, 2024-02-01) -
BEECH: a dose-finding run-in followed by a randomised phase II study assessing the efficacy of AKT inhibitor capivasertib (AZD5363) combined with paclitaxel in patients with estrogen receptor-positive advanced or metastatic breast cancer, and in a PIK3CA mutant sub-population
(Oxford University Press, 2019-05-01) -
Bempegaldesleukin Plus Nivolumab in Untreated Advanced Melanoma: The Open-Label, Phase III PIVOT IO 001 Trial Results
(American Society of Clinical Oncology, 2023-10-20) -
Benchmarking of robotic and laparoscopic spleen-preserving distal pancreatectomy by using two different methods
(Oxford University Press, 2023-01) -
Benchmarking the Extent and Speed of Reperfusion: First Pass TICI 2c-3 Is a Preferred Endovascular Reperfusion Endpoint
(Frontiers Media, 2021-05-11) -
BET inhibitor trotabresib in heavily pretreated patients with solid tumors and diffuse large B-cell lymphomas
(Nature Portfolio, 2023-03-13) -
Bevacizumab, Irinotecan, or Topotecan Added to Temozolomide for Children With Relapsed and Refractory Neuroblastoma: Results of the ITCC-SIOPEN BEACON-Neuroblastoma Trial
(American Society of Clinical Oncology, 2024-04-01)